Back to Search
Start Over
Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant
- Source :
- PR Newswire. February 7, 2022
- Publication Year :
- 2022
-
Abstract
- ASC10-A demonstrated strong in vitro antiviral activity against multiple SARS-CoV-2 virus variants including Omicron By applying a double prodrug strategy, ASC10's permeability in Caco-2 cells and ASC10's oral bioavailability in [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.692202108